Aehr Test Systems (AEHR) Set to Announce Earnings on Tuesday

Aehr Test Systems (NASDAQ:AEHR) is scheduled to announce its earnings results after the market closes on Tuesday, April 9th. Analysts expect the company to announce earnings of ($0.04) per share for the quarter. Aehr Test Systems has set its FY 2024 guidance at EPS and its Q2 guidance at $0.23 EPS.Investors that are interested in registering for the company’s conference call can do so using this link.

Aehr Test Systems (NASDAQ:AEHR) last released its quarterly earnings data on Tuesday, January 9th. The semiconductor company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Aehr Test Systems had a return on equity of 26.97% and a net margin of 25.76%. The company had revenue of $21.43 million for the quarter, compared to analyst estimates of $20.10 million. On average, analysts expect Aehr Test Systems to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Aehr Test Systems Stock Performance

NASDAQ:AEHR opened at $11.34 on Friday. Aehr Test Systems has a 52-week low of $10.53 and a 52-week high of $54.10. The firm has a market cap of $327.16 million, a price-to-earnings ratio of 15.97 and a beta of 1.97. The business’s fifty day moving average is $15.27 and its 200 day moving average is $23.75.

Wall Street Analyst Weigh In

Several research firms recently commented on AEHR. William Blair restated a “market perform” rating on shares of Aehr Test Systems in a research report on Monday, March 25th. Craig Hallum restated a “hold” rating and set a $12.00 target price on shares of Aehr Test Systems in a research report on Tuesday, March 26th. Finally, StockNews.com upgraded Aehr Test Systems from a “sell” rating to a “hold” rating in a research report on Friday, January 19th.

Insider Buying and Selling

In other news, VP Avijit K. Ray-Chaudhuri acquired 3,000 shares of the business’s stock in a transaction dated Friday, January 12th. The stock was purchased at an average cost of $17.87 per share, for a total transaction of $53,610.00. Following the acquisition, the vice president now owns 9,719 shares of the company’s stock, valued at $173,678.53. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, VP Avijit K. Ray-Chaudhuri acquired 3,000 shares of the business’s stock in a transaction dated Friday, January 12th. The stock was purchased at an average cost of $17.87 per share, for a total transaction of $53,610.00. Following the acquisition, the vice president now owns 9,719 shares of the company’s stock, valued at $173,678.53. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gayn Erickson sold 4,871 shares of the company’s stock in a transaction dated Thursday, January 18th. The stock was sold at an average price of $17.39, for a total value of $84,706.69. Following the completion of the transaction, the chief executive officer now owns 427,935 shares of the company’s stock, valued at $7,441,789.65. The disclosure for this sale can be found here. Insiders sold a total of 8,738 shares of company stock worth $151,723 over the last ninety days. 11.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Aehr Test Systems

Institutional investors have recently bought and sold shares of the stock. Lazard Asset Management LLC purchased a new stake in Aehr Test Systems during the 4th quarter valued at about $34,000. Deutsche Bank AG bought a new position in Aehr Test Systems during the 1st quarter valued at approximately $40,000. PNC Financial Services Group Inc. raised its position in Aehr Test Systems by 93.0% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,158 shares of the semiconductor company’s stock valued at $48,000 after purchasing an additional 558 shares during the last quarter. Citigroup Inc. raised its position in Aehr Test Systems by 463.8% during the 4th quarter. Citigroup Inc. now owns 2,458 shares of the semiconductor company’s stock valued at $49,000 after purchasing an additional 2,022 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its position in Aehr Test Systems by 1,027.1% during the 1st quarter. JPMorgan Chase & Co. now owns 1,578 shares of the semiconductor company’s stock valued at $49,000 after purchasing an additional 1,438 shares during the last quarter. 69.69% of the stock is currently owned by hedge funds and other institutional investors.

Aehr Test Systems Company Profile

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.